secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexeo Therapeutics, Inc. (LXEO)
CIK:        0001907108
Form:       8-K
Filed at:   2026-06-29T21:06:22+00:00
Accession:  0001193125-26-288703
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lexeo Therapeutics reports 2026 annual meeting results; all director nominees elected
--------------------------------------------------------------------------------

- Elected Class III directors Townsend (64.7M FOR), Cooperstone (48.8M FOR), and Cholmondeley (64.7M FOR); broker non-votes ~10M each.
- Ratified KPMG as independent auditor for fiscal 2026: 75.5M FOR, 55.6K AGAINST, 30.1K abstain.
- Annual Meeting held virtually on June 25, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907108/000119312526288703/0001193125-26-288703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907108/000119312526288703/lxeo-20260625.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-288703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer